New York needs to step up for veterans' mental health care

Veterans in New York face a growing mental health crisis, with suicide rates far higher than the general population. Last year saw the highest veteran suicide rate in over two decades - nearly 25 per 100, 000 people compared to just 19. 8 the year before. That's more than double the rate for non-veterans. Behind these stark numbers are real people carrying invisible wounds from their service. Research shows over half of patients with psychiatric disorders don't respond to standard treatments. With no new anxiety medications approved in 25 years, veterans often cycle through ineffective options while their conditions worsen. The mental health system hasn't evolved to meet their needs. But change is finally coming through innovative treatments using controlled substances like LSD, psilocybin and MDMA, which show real promise for conditions like PTSD and treatment-resistant depression.New York currently has no clear process for approving these breakthrough treatments once federal regulators approve them. While federal agencies carefully evaluate each drug's safety and effectiveness, state processes create bottlenecks that leave veterans waiting. The state doesn't need to duplicate federal oversight - it just needs clear, responsive regulations that allow approved treatments to reach veterans quickly. It's important to understand these treatments would be tightly controlled, not widely available. Each drug would be evaluated individually and only used in medical settings under professional supervision. One approval wouldn't open the floodgates to recreational use. For the 560, 000 veterans in New York, getting these treatments sooner could mean the difference between life and death.